COGT · ISSUER CIK 1622229
Cogent Biosciences, Inc.
Between Aug 1, 2026 and Oct 29, 2026, 1 Cogent Biosciences, Inc. insiders reported $0.00 of open-market purchases and $1.7M of sales on SEC Form 4.
↗1 insiders filed
Original Form 4 filings from Aug 1, 2026 to Oct 29, 2026. 1 of 1 sales were reported under a 10b5-1 plan.
$0.00Insider buying
$1.7MInsider selling
−$1.7MNet open-market
Aug 31, 2026Latest filing
| Ticker | Insider | Type | Owned | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Aug 31, 202617:01 | Aug 27, 2026 | COGT | Director | S · Sell10b5-1 | $37.12 | −45,510 | 0 | -100% | −$1.7M | ||
| Aug 31, 202617:01 | Aug 27, 2026 | COGT | Director | M · Exercise10b5-1 | $5.39 | +45,510 | 45,510 | New | $245K |